Claritas Pharmaceuticals (CLAZF) Stock Price, Quote, News & History

Q: What sector and industry does Claritas Pharmaceuticals (CLAZF) operate in?

Claritas Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.

Comments

Claritas Pharmaceuticals Inc (CLAZF) Stock Price, Quote, News & History

CLAZFOTCEM

Logo brought to you by Benzinga Data

Trade with Public

$0.000001

At close: Feb 6, 4:00 PM EST

Overview

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

Volume / Avg.

0 / 563.00

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

$36.00

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Claritas Pharmaceuticals Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-953.00K

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

Free Cash Flow (TTM)

-953.00K

Capital Expenditure (TTM)

Net Change in Cash (TTM)

Valuation Metrics

Enterprise Value

$365.00

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$548.00K

LT Debt

$10.00K

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$2.00K

Debt to Equity

0.17

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 563.00

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

$36.00

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Claritas Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company developing a portfolio of pharmaceutical products in Canada. It develops new treatments for a variety of diseases and disorders, by discovering, developing, manufacturi...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Claritas Pharmaceuticals (CLAZF) stock?

You can purchase shares of Claritas Pharmaceuticals (OTCEM:CLAZF) through any online brokerage.

View our list of the best stock brokerages

Who are Claritas Pharmaceuticals (CLAZF) competitors?

There are no as such competitors for Claritas Pharmaceuticals.

What is the forecast, or price target, for Claritas Pharmaceuticals (CLAZF) stock?

There is no analysis for Claritas Pharmaceuticals to provide a consensus price target.

What is the current price for Claritas Pharmaceuticals (CLAZF)?

The stock price for Claritas Pharmaceuticals (OTCEM: CLAZF) is $0.000001 last updated December 16, 2025 at 12:15 PM EST.

Does Claritas Pharmaceuticals (CLAZF) pay a dividend?

There are no upcoming dividends for Claritas Pharmaceuticals.

When is Claritas Pharmaceuticals (OTCEM:CLAZF) reporting earnings?

Claritas Pharmaceuticals does not have any upcoming earnings scheduled.

Is Claritas Pharmaceuticals (CLAZF) going to split?

There is no upcoming split for Claritas Pharmaceuticals.

What sector and industry does Claritas Pharmaceuticals (CLAZF) operate in?

Claritas Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

Volume / Avg.

0 / 563.00

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

$36.00

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Claritas Pharmaceuticals Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-953.00K

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

Free Cash Flow (TTM)

-953.00K

Capital Expenditure (TTM)

Net Change in Cash (TTM)

Valuation Metrics

Enterprise Value

$365.00

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$548.00K

LT Debt

$10.00K

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$2.00K

Debt to Equity

0.17

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 563.00

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

$36.00

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Claritas Pharmaceuticals (CLAZF) stock?

You can purchase shares of Claritas Pharmaceuticals (OTCEM:CLAZF) through any online brokerage.

View our list of the best stock brokerages

Who are Claritas Pharmaceuticals (CLAZF) competitors?

There are no as such competitors for Claritas Pharmaceuticals.

What is the forecast, or price target, for Claritas Pharmaceuticals (CLAZF) stock?

There is no analysis for Claritas Pharmaceuticals to provide a consensus price target.

What is the current price for Claritas Pharmaceuticals (CLAZF)?

The stock price for Claritas Pharmaceuticals (OTCEM: CLAZF) is $0.000001 last updated December 16, 2025 at 12:15 PM EST.

Does Claritas Pharmaceuticals (CLAZF) pay a dividend?

There are no upcoming dividends for Claritas Pharmaceuticals.

When is Claritas Pharmaceuticals (OTCEM:CLAZF) reporting earnings?

Claritas Pharmaceuticals does not have any upcoming earnings scheduled.

Is Claritas Pharmaceuticals (CLAZF) going to split?

There is no upcoming split for Claritas Pharmaceuticals.

What sector and industry does Claritas Pharmaceuticals (CLAZF) operate in?

Claritas Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.